Karo Bio and GPC Biotech Successfully Develop Ten Assays for Novel Anibacterial Targets
06-Feb-2002 -
MARTINSRIED/MUNICH, Germany, WALTHAM/BOSTON, Mass., HUDDINGE, Sweden, and DURHAM, N.C., Feb. 6, 2002 (PRIMEZONE) -- Karo
Bio USA, Inc., a wholly owned subsidiary of Karo Bio AB,
and GPC Biotech AG (Frankfurt Stock Exchange: GPC) today
announced that their technology collaboration has been ...
antibiotics
biotechnology
Germany
+4